Elizabeth Chalmers

12PUBLICATIONS
30CO-AUTHORS
Cardiology (incl. cardiovascular diseases)HaematologyCardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 13, 2024
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease.

Manuela Albisetti, Igor Tartakovsky, Jacqueline Halton

|Feb 22, 2023
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).

Caroline Wall, Hua Xiang, Ben Palmer

|Sep 23, 2022
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.

Leonardo R Brandão, Igor Tartakovsky, Manuela Albisetti

|Aug 17, 2021
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.

Daniel P Hart, Jayanthi Alamelu, Neha Bhatnagar

|Aug 03, 2018
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.

P W Collins, R Liesner, M Makris

|Jul 14, 2018
The immunogenicity of ReFacto AF (moroctocog alfa AF-CC) in previously untreated patients with haemophilia A in the United Kingdom.

M C Mathias, P W Collins, B P Palmer

Pageof 2

Frequent Collaborators

4 joint publications

Charles R M Hay

3 joint publications

Tina T Biss

2 joint publications

Michael Makris

2 joint publications

Pratima Chowdary